Found 7 matching trials
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine PHASE1 This study is an open-label combined randomized double-blind, positive cont...
Show More Location
Henan Center for Diseases Control and Prevention
Learn More & Join Trial
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks) PHASE3 This is a Phase 3 randomized, observation-blinded, active-controlled, paral...
Show More Status
Active Not Recruiting
Location
Faculty of Medicine Siriraj Hospital, Mahidol University
Learn More & Join Trial
A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13 PHASE3 The goal of this clinical trial is to evaluate the immunogenicity and safet...
Show More Location
RSUP Prof. Dr. I.G.N.G Ngoerah
Learn More & Join Trial
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) PHASE3 Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Show More Location
Neihuang Center for Disease Control and Prevention
Learn More & Join Trial
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above PHASE1 Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Show More Location
Neihuang Center for Disease Control and Prevention
Learn More & Join Trial
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) PHASE3 The primary objectives of this study are to evaluate the immunogenicity and...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants PHASE2 The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Show More Location
GSK Investigational Site
Learn More & Join Trial